In the meantime, a favorable prognosis was observed in reduced LAYN expression for HNSCC patients, which was in accordance with our previous results (HR = 2.508, 95% CI 1.075–5.851, P = 0.033) (Fig. 5B, C). This evidence concerns the gene LAYN and head and neck squamous cell carcinoma.